During the past decade, Lund University Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 7 clinical trials were completed, i.e. on average, 20.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lund University Hospital" #1 sponsor was "Lund University Hospital" with 15 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored, "Region Skane" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Abbott" with 4 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lund University Hospital" #1 collaborator was "Lund University" with 4 trials as a collaborator, "Lund University Hospital" with 4 trials as a collaborator, "Aarhus University Hospital" with 3 trials as a collaborator, "Karolinska University Hospital" with 3 trials as a collaborator and "Nordic Lymphoma Group" with 3 trials as a collaborator. Other collaborators include 182 different institutions and companies that were collaborators in the rest 175 trials.

According to Clinical.Site data, the most researched conditions in "Lund University Hospital" are "Lymphoma" (5 trials), "Breast Cancer" (4 trials), "Coronary Artery Disease" (4 trials), "Multiple Myeloma" (4 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Lund University Hospital" in a lesser frequency.

Most popular intervention types in "Lund University Hospital" are "Drug" (58 trials), "Procedure" (14 trials), "Device" (12 trials), "Other" (11 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "conventional surgery" (4 trials), "Lenalidomide" (3 trials), "cisplatin" (3 trials) and "cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lund University Hospital" are 79 trials for "All" genders, 9 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Lund University Hospital". 1 are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Lund University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Lund University Hospital, 8 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 17 trials that are defined as “Not Applicable".